Scinai Immunotherapeutics Ltd.
SCNI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$2,067 | -$2,067 | -$2,230 |
| Dep. & Amort. | – | $352 | $352 | $499 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $135 | $135 | $204 |
| Change in WC | – | $135 | $135 | $475 |
| Other Non-Cash | – | $158 | $158 | -$24 |
| Operating Cash Flow | – | -$1,288 | -$1,288 | -$1,076 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | -$6 | -$6 | -$0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | -$6 | -$6 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $2,012 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | $791 | $791 | -$12 |
| Financing Cash Flow | – | $791 | $791 | $2,000 |
| Forex Effect | – | $21 | $21 | $2 |
| Net Chg. in Cash | – | $0 | -$2,095 | $926 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $0 | $2,095 | $1,169 |
| End Cash | – | $0 | $0 | $2,095 |
| Free Cash Flow | – | -$1,294 | -$1,294 | -$1,076 |